Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression

Cell

Volumn 93, Issue 3, 1998, Pages 445-454

  Nachtigal, Mark W ^a   Hirokawa, Yoshifumi ^a   Enyeart VanHouten, Debra L ^a   Flanagan, John N ^a   Hammer, Gary D ^a   Ingraham, Holly A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; MUELLERIAN INHIBITING FACTOR;

ARTICLE; DENYS DRASH SYNDROME; DNA BINDING; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GONAD DEVELOPMENT; HUMAN; HUMAN CELL; MALE PSEUDOHERMAPHRODITISM; MISSENSE MUTATION; PRIORITY JOURNAL; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; TRANSACTIVATION; X CHROMOSOME LINKAGE;

MAMMALIA;

EID: 0032076964     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81172-1     Document Type: Article

References (45)

1. Allgood, V.E., Zhang, Y., O'Malley, B.W., and Weigel, N.L. (1997). Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer. Biochemistry 36, 224-232.
2. Barbaux, S., Niaudet, P., Gubler, M.C., Grunfeld, J.P., Jaubert, F., Kuttenn, F., Fekete, C.N., Souleyreau, T.N., Thibaud, E., Fellous, M., et al. (1997). Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17, 467-470.
3. Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., et al. (1990). Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60, 509-520.
4. Englert, C., Vidal, M., Maheswaran, S., Ge, Y., Ezzell, R.M., Isselbacher, K.J., and Haber, D.A. (1995). Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. USA 92, 11960-11964.
5. Foster, J.W., Dominguez, S.M., Guioli, S., Kowk, G., Weller, P.A., Stevanovic, M., Weissenbach, J., Mansour, S., Young, I.D., Goodfellow, P.N., et al. (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525-530.
6. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H., and Bruns, G.A. (1990). Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343, 774-778.
7. Giuili, G., Shen, W.H., and Ingraham, H.A. (1997). The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian inhibiting substance, in vivo. Development 124, 1799-1807.
8. Guo, W., Lovell, R.S., Zhang, Y.H., Huang, B.L., Burris, T.P., Craigen, W.J., and McCabe, E.R. (1996). Ahch, the mouse homologue of DAX1: cloning, characterization and synteny with Gyk, the glycerol kinase locus. Gene 178, 31-34.
9. Hatano, O., Takayama, K., Imai, T., Waterman, M.R., Takakusu, A., Omura, T., and Morohashi, K. (1994). Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120, 2787-2797.
10. Ikeda, Y., Luo, X., Abbud, R., Nilson, J.H., and Parker, K.L (1995). The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9, 478-486.
11. Ikeda, Y., Swain, A., Weber, T.J., Hentges, K.E., Zanaria, E., Lalli, E., Tamai, K.T., Sassone, C.P., Lovell, B.R., Camerino, G., et al. (1996). Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 10, 1261-1272.
12. Ingraham, H.A., Flynn, S.E., Voss, J.W., Albert, V.R., Kapiloff, M.S., Wilson, L., and Rosenfeld, M.G. (1990). The POU-specific domain of Pit-1 is essential for high affinity, sequence specific DNA binding and DNA-dependent Pit-1 - Pit-1 interactions. Cell 61, 1021-1033.
13. Ingraham, H.A., Lala, D.S., Ikeda, Y., Luo, X., Shen, W.H., Nachtigal, M.W., Abbud, R., Nilson, J.H., and Parker, K.L. (1994). The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8, 2302-2312.
14. Ito, M., Yu, R., and Jameson, J.L. (1997). DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17, 1476-1483.
15. Kent, J., Wheatley, S.C., Andrews, J.E., Sinclair, A.H., and Koopman, P. (1996). A male-specific role for SOX9 in vertebrate sex determination. Development 122, 2813-2822.
16. Koopman, P., Munsterberg, A., Capel, B., Vivian, N., and Lovell-Badge, R. (1990). Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 348, 450-452.
17. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. (1993). WT-1 is required for early kidney development. Cell 74, 679-691.
18. Lala, D.S., Syka, P.M., Lazarchik, S.B., Mangelsdorf, D.J., Parker, K.L., and Heyman, R.A. (1997). Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc. Natl. Acad. Sci. USA 94, 4895-4900.
19. Lalli, E., Bardoni, B., Zazopoulos, E., Wurtz, J.M., Strom, T.M., Moras, D., and Sassone, C.P. (1997). A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol. Endocrinol. 11, 1950-1960.
20. Larsson, S.H., Charlieu, J.P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van, H.V., and Hastie, N.D. (1995). Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81, 391-401.
21. Lee, S.L., Sadovsky, Y., Swirnoff, A.H., Polish, J.A., Goda, P., Gavrilina, G., and Milbrandt, J. (1996). Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273, 1219-1221.
22. Little, M., and Wells, C. (1997). A clinical overview of WT1 gene mutations. Hum. Mutat. 9, 209-225.
23. Luo, X., Ikeda, Y., and Parker, K.L. (1994). A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77, 481-490.
24. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
25. Moffett, P., Bruening, W., Nakagama, H., Bardeesy, N., Housman, D., Housman, D.E.,and Pelletier, J. (1995). Antagonism of WT1 activity by protein self-association. Proc. Natl. Acad. Sci. USA 92, 11105-11109.
26. Muscatelli, F., Strom, T.M., Walker, A.P., Zanaria, E., Recan, D., Meindl, A., Bardoni, B., Guioli, S., Zehetner, G., Rabl, W., et al. (1994). Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372, 672-676.
27. Nakagama, H., Heinrich, G., Pelletier, J., and Housman, D.E. (1995). Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol. Cell. Biol. 15, 1489-1498.
28. Parker, K.L., and Schimmer, B.P. (1997). Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr. Rev. 18, 361-377.
29. Pelletier, J., Bruening, W., Kashtan, C.E., Mauer, S.M., Manivel, J.C., Striegel, J.E., Houghton, D.C., Junien, C., Habib, R., Fouser, L., et al. (1991a). Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67, 437-447.
30. Pelletier, J., Schalling, M., Buckler, A.J., Rogers, A., Haber, D.A., and Housman, D. (1991b). Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5, 1345-1356.
31. Perlmann, T., and Evans, R.M. (1997). Nuclear receptors in Sicily: all in the famiglia. Cell 90, 391-397.
32. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., et al. (1990). The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346, 194-197.
33. Reddy, J.C., and Licht, J.D. (1996). The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochim. Biophys. Acta 1287, 1-28.
34. Reddy, J.C., Morris, J.C., Wang, J., English, M.A., Haber, D.A., Shi, Y., and Licht, J.D. (1995). WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 270, 10878-10884.
35. Sadovsky, Y., Crawford, P.A., Woodson, K.G., Polish, J.A., Clements, M.A., Tourtellotte, L.M., Simburger, K., and Milbrandt, J. (1995). Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of cortico-steroids. Proc. Natl. Acad. Sci. USA 92, 10939-10943.
36. Shen, W.H., Moore, G.G., Ikeda, Y., Parker, K.L., and Ingraham, H.A. (1994). Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77, 651-661.
37. Shinoda, K., Yoshii, H., Nomura, M., Nagano, M., Shiba, H., Sasaki, H., Osawa, Y., Ninomiya, Y., Niwa, O., Morohashi, K.-I., et al. (1995). Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev. Dyn. 204, 22-29.
38. Sinclair, A.H., Berta, P., Palmer, M.S., Hawkins, J.R., Griffiths, B.L., Smith, M.J., Foster, J.W., Frischauf, A.-M., Lovell-Badge, R., and Goodfellow, P.N. (1990). A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346, 240-244.
39. Swain, A., Zanaria, E., Hacker, A., Lovell-Badge, R., and Camerino, G. (1996). Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 12, 404-409.
40. Swain, A., Narvaez, V., Burgoyne, P., Camerino, G., and Lovell-Badge, R. (1998). Dax1 antagonizes Sry action in mammalian sex determination. Nature 391, 761-767.
41. Tamai, KT., Monaco, L., Alastalo, T.P., Lalli, E., Parvinen, M., and Sassone, C.P. (1996). Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol. Endocrinol. 10, 1561-1569.
42. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F.D., Keutel, J., Hustert, E., et al. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120.
43. Zanaria, E., Muscatelli, F., Bardoni, B., Strom, T.M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A.P., McCabe, E.R., et al. (1994). An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372, 635-641.
44. Zazopoulos, E., Lalli, E., Stocco, D.M., and Sassone, C.P. (1997). DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390, 311-315.
45. Zhang, P., and Mellon, S.H. (1996). The orphan nuclear receptor steroidogenic factor-1 regulates the cAMP-mediated transcriptional activation of rat cytochrome P450c17. Mol. Endocrinol. 6, 1249-1258.